Genovese Michele, Guidone Daniela, Buccirossi Martina, Borrelli Anna, Rodriguez-Gimeno Alejandra, Bertozzi Fabio, Bandiera Tiziano, Galietta Luis J V
Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, 80078 Naples, Italy.
D3 PharmaChemistry, Italian Institute of Technology (IIT), Via Morego, 3016163, Genoa, Italy.
PNAS Nexus. 2022 Dec 9;2(1):pgac288. doi: 10.1093/pnasnexus/pgac288. eCollection 2023 Jan.
Pharmacological modulators of the Ca signaling cascade are important research tools and may translate into novel therapeutic strategies for a series of human diseases. We carried out a screening of a maximally diverse chemical library using the Ca-sensitive Cl channel TMEM16A as a functional readout. We found compounds that were able to potentiate UTP-dependent TMEM16A activation. Mechanism of action of these compounds was investigated by a panel of assays that looked at intracellular Ca mobilization triggered by extracellular agonists or by caged-IP photolysis, PIP breakdown by phospholipase C, and ion channel activity on nuclear membrane. One compound appears as a selective potentiator of inositol triphosphate receptor type 1 (ITPR1) with a possible application for some forms of spinocerebellar ataxia. A second compound is instead a potentiator of the P2RY2 purinergic receptor, an activity that could promote fluid secretion in dry eye and chronic obstructive respiratory diseases.
钙信号级联的药理学调节剂是重要的研究工具,可能转化为一系列人类疾病的新型治疗策略。我们以钙敏感氯离子通道TMEM16A作为功能读数,对一个极度多样化的化学文库进行了筛选。我们发现了能够增强UTP依赖性TMEM16A激活的化合物。通过一系列检测来研究这些化合物的作用机制,这些检测包括观察细胞外激动剂或笼锁式肌醇三磷酸(caged-IP)光解引发的细胞内钙动员、磷脂酶C导致的磷脂酰肌醇-4,5-二磷酸(PIP)分解以及核膜上的离子通道活性。一种化合物表现为1型肌醇三磷酸受体(ITPR1)的选择性增强剂,可能对某些形式的脊髓小脑共济失调有应用价值。相反,第二种化合物是P2RY2嘌呤能受体的增强剂,这种活性可能促进干眼症和慢性阻塞性呼吸道疾病中的液体分泌。